Dr. Gaulin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-650-5000
Summary
- Dr. Charles Gaulin is an oncologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from University of Sydney Faculty of Medicine and has been in practice 1 year. He also speaks multiple languages, including French. He specializes in hematologic oncology and is experienced in multiple myeloma, hematology, oncology, and lymphoma. He has 7 publications and over 50 citings.
Education & Training
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2016 - 2019
- University of Sydney Faculty of MedicineClass of 2015, MBBS
- University of British ColumbiaBS, 2007 - 2011
Certifications & Licensure
- NH State Medical License 2024 - 2026
- VT State Medical License 2024 - 2026
- AZ State Medical License 2020 - 2025
- MN State Medical License 2021 - 2022
- NY State Medical License 2019 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Characteristics, treatment, and outcomes of mantle cell lymphoma with cutaneous involvement: a decade-long study at MD Anderson cancer center.Jared R Zhang, Susan Y Wu, Preetesh Jain, Chi Young Ok, Fangfang Yan
Leukemia & Lymphoma. 2024-11-01 - Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms.Charles Gaulin, Fiona Craig, Shannon Fortin Ensign, Ryan Robetorye, Sarah Gibson
Leukemia & Lymphoma. 2023-12-01 - 2 citationsRoutine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer.Giulia Petrone, Charles Gaulin, Andriy Derkach, Ashwin Kishtagari, Mark E Robson
Haematologica. 2023-01-01
Other Languages
- French
External Links
- LinkedInhttps://www.linkedin.com/in/charles-gaulin-3797b67b
- Google Scholar Profilehttps://scholar.google.com/citations?user=oodurEQAAAAJ&hl=en
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: